203 related articles for article (PubMed ID: 1885775)
1. Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis.
Opal SM; Cross AS; Sadoff JC; Collins HH; Kelly NM; Victor GH; Palardy JE; Bodmer MW
J Clin Invest; 1991 Sep; 88(3):885-90. PubMed ID: 1885775
[TBL] [Abstract][Full Text] [Related]
2. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
Calandra T; Baumgartner JD; Glauser MP
Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of combination immunotherapy in experimental Pseudomonas sepsis.
Cross AS; Opal SM; Palardy JE; Bodmer MW; Sadoff JC
J Infect Dis; 1993 Jan; 167(1):112-8. PubMed ID: 8418157
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody to tumor necrosis factor-alpha attenuates plasma interleukin-6 levels in porcine gram-negative sepsis.
Mullen PG; Fisher BJ; Walsh CJ; Susskind BM; Leeper-Woodford SK; Jesmok GJ; Fowler AA; Sugerman HJ
J Surg Res; 1994 Nov; 57(5):625-31. PubMed ID: 7967599
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of Pseudomonas aeruginosa pyelonephritis in neutropenic mice with human antilipopolysaccharide monoclonal antibody and cefsulodin.
Ishibashi K; Yamaguchi O; Shiraiwa Y; Ogihara M; Shigeta S
J Urol; 1996 Jun; 155(6):2094-7. PubMed ID: 8618343
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis.
Dunn DL; Bogard WC; Cerra FB
Surgery; 1985 Aug; 98(2):283-90. PubMed ID: 3895540
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
Pallua N; Low JF; von Heimburg D
Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody to tumor necrosis factor--alpha prevents lethal endotoxin sepsis in adult rhesus monkeys.
Fiedler VB; Loof I; Sander E; Voehringer V; Galanos C; Fournel MA
J Lab Clin Med; 1992 Oct; 120(4):574-88. PubMed ID: 1402333
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model.
Emerson TE; Lindsey DC; Jesmok GJ; Duerr ML; Fournel MA
Circ Shock; 1992 Oct; 38(2):75-84. PubMed ID: 1423924
[TBL] [Abstract][Full Text] [Related]
11. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
[TBL] [Abstract][Full Text] [Related]
12. Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites.
Francés R; Chiva M; Sánchez E; González-Navajas JM; Llovet T; Zapater P; Soriano G; Muñoz C; Balanzó J; Pérez-Mateo M; Song XY; Guarner C; Such J
J Hepatol; 2007 May; 46(5):797-803. PubMed ID: 17321632
[TBL] [Abstract][Full Text] [Related]
13. Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody.
Hinshaw LB; Emerson TE; Taylor FB; Chang AC; Duerr M; Peer GT; Flournoy DJ; White GL; Kosanke SD; Murray CK
J Trauma; 1992 Oct; 33(4):568-73. PubMed ID: 1433404
[TBL] [Abstract][Full Text] [Related]
14. Anti-lipopolysaccharide monoclonal antibodies inhibit macrophage TNF messenger RNA synthesis in vitro.
Battafarano RJ; Burd RS; Cody CS; Kellogg TA; Raymond CS; Ratz CA; Dunn DL
J Surg Res; 1993 Apr; 54(4):342-8. PubMed ID: 8331928
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine.
Jesmok G; Lindsey C; Duerr M; Fournel M; Emerson T
Am J Pathol; 1992 Nov; 141(5):1197-207. PubMed ID: 1443053
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa.
Opal SM; Cross AS; Kelly NM; Sadoff JC; Bodmer MW; Palardy JE; Victor GH
J Infect Dis; 1990 Jun; 161(6):1148-52. PubMed ID: 2140582
[TBL] [Abstract][Full Text] [Related]
17. Effect of treatment with a monoclonal antibody against equine tumor necrosis factor (TNF) on clinical, hematologic, and circulating TNF responses of miniature horses given endotoxin.
Cargile JL; MacKay RJ; Dankert JR; Skelley L
Am J Vet Res; 1995 Nov; 56(11):1451-9. PubMed ID: 8585655
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of interleukin-6 in the development of sepsis. Part I: Study in a standardized contact burn murine model.
Pallua N; von Heimburg D
Crit Care Med; 2003 May; 31(5):1490-4. PubMed ID: 12771623
[TBL] [Abstract][Full Text] [Related]
19. [Effects of specific removal of circulating tumor necrosis factor-alpha by immunoadsorption on nitric oxide in endotoxin shock].
Long H; Zhang X; Hou F
Zhonghua Yi Xue Za Zhi; 1998 Jan; 78(1):23-6. PubMed ID: 10923398
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
